PRME NASDAQ
Prime Medicine, Inc.
1W: -5.8%
1M: -25.5%
3M: -9.8%
YTD: -16.4%
1Y: +150.0%
3Y: -76.5%
$2.97
+0.02 (+0.68%)
After Hours: $3.21 (+0.24, +8.08%)
Weekly Expected Move ±7.3%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$536.4M
52W Range1.18-6.94
Volume2,208,100
Avg Volume2,530,790
Beta2.36
Dividend—
Analyst Ratings
Company Info
CEOAllan Reine
Employees214
SectorHealthcare
IndustryBiotechnology
IPO Date2022-10-20
Websiteprimemedicine.com
21 Erie Street
Cambridge, MA 02139
US
Cambridge, MA 02139
US
617-564-0013
About Prime Medicine, Inc.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Latest News
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Makhni Svetlana Ni | A-Award | 800,000 | $3.67 | 2026-04-16 |
| Makhni Svetlana Ni | 0 | — | 2026-04-16 | |
| Reine Allan | A-Award | 1,300,000 | $4.38 | 2026-02-26 |
| LEE ANN L. | A-Award | 375,000 | $3.34 | 2026-02-23 |
| Alenson Carman | A-Award | 140,000 | $3.34 | 2026-02-23 |